Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

RXR/RAR receptor modulators claimed by CIRD Galderma for skin and other disorders

Sep. 9, 1998

Biotech Australia announces encouraging early clinical trial results with leg ulcer treatment

Sep. 4, 1998

Leo describes potent vitamin D3 derivatives with low calcemic activity

Sep. 3, 1998

Keratinocyte growth factor to enter phase II clinical trials

Sep. 3, 1998

Access signs development agreement with ViroTex for amlexanox formulations

Sep. 1, 1998

Access signs licensing agreement with Paladin to market amlexanox in Canada

Aug. 27, 1998

Incert appears to prevent the formation of postoperative adhesions

Aug. 26, 1998

Toray reports kappa agonists for treating dermatological disorders

Aug. 25, 1998

Access licensee files for U.K. approval of amlexanox oral paste

Aug. 24, 1998

Wound-healing asiatic acid derivatives under investigation at Dong Kook

Aug. 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...